二甲双胍与心血管疾病风险 - Suppr

Metformin and risk of cardiovascular disease.

作者信息

Turner R C, Holman R R

机构信息

Diabetes Research Laboratories, Oxford, UK.

出版信息

Cardiology. 1999;91(3):203-4. doi: 10.1159/000006910.

DOI:10.1159/000006910

PMID:10516415

Abstract

摘要

相似文献

Metformin and risk of cardiovascular disease.

Cardiology. 1999;91(3):203-4. doi: 10.1159/000006910.

Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials.

Diabetes Obes Metab. 2011 Mar;13(3):221-8. doi: 10.1111/j.1463-1326.2010.01349.x.

[Not Available].

Praxis (Bern 1994). 2016 Sep;105(20):1221-1222. doi: 10.1024/1661-8157/a002501.

Antihyperglycemic treatment in diabetics with coronary disease: increased metformin-associated mortality over a 5-year follow-up.

Cardiology. 1999;91(3):195-202. doi: 10.1159/000006909.

Intensive glucose lowering treatment in type 2 diabetes.

BMJ. 2011 Jul 26;343:d4243. doi: 10.1136/bmj.d4243.

Sulphonylurea-metformin combination therapy, cardiovascular disease and all-cause mortality: the Fremantle Diabetes Study.

Diabetes Obes Metab. 2010 Sep;12(9):757-65. doi: 10.1111/j.1463-1326.2010.01230.x.

Comment on: Evans JMM, Ogston SA, Emslie-Smith A, Morris AD (2006) risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930-936.

Diabetologia. 2006 Nov;49(11):2807-8. doi: 10.1007/s00125-006-0404-3. Epub 2006 Sep 6.

Intensive glucose lowering and cardiovascular disease prevention in diabetes: reconciling the recent clinical trial data.

Circulation. 2010 Nov 23;122(21):2201-11. doi: 10.1161/CIRCULATIONAHA.109.913350.

[Macrovascular secondary prevention with pioglitazone in diabetics. PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events)].

Internist (Berl). 2007 Jan;48(1):89-90; discussion 90-1. doi: 10.1007/s00108-006-1777-6.

All-cause mortality and cardiovascular effects associated with the DPP-IV inhibitor sitagliptin compared with metformin, a retrospective cohort study on the Danish population.

Diabetes Obes Metab. 2014 Mar;16(3):231-6. doi: 10.1111/dom.12197. Epub 2013 Sep 10.

引用本文的文献

Sulfonylurea use and incident cardiovascular disease among patients with type 2 diabetes: prospective cohort study among women.

Diabetes Care. 2014 Nov;37(11):3106-13. doi: 10.2337/dc14-1306. Epub 2014 Aug 22.

Metformin and mortality.

Diabetologia. 2013 Apr;56(4):937-8. doi: 10.1007/s00125-013-2843-y. Epub 2013 Feb 2.

Metformin and its clinical use: new insights for an old drug in clinical practice.

Arch Med Sci. 2012 Nov 9;8(5):907-17. doi: 10.5114/aoms.2012.31622. Epub 2012 Nov 7.

Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials.

Diabetologia. 2012 Oct;55(10):2593-2603. doi: 10.1007/s00125-012-2653-7. Epub 2012 Aug 10.

Management of Diabetes with Coronary Artery Disease.

Curr Treat Options Cardiovasc Med. 2003 Feb;5(1):75-88. doi: 10.1007/s11936-003-0016-x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Metformin and risk of cardiovascular disease.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献